United Microelectronics Corp
TWSE:2303
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
41.45
57.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
United Microelectronics Corp
You don't have any saved screeners yet
Welcome everyone to UMC's 2018 Second Quarter Earnings Conference Call. [Operator Instructions] And for your information, this conference call is now being broadcasted live over the Internet. Webcast replay will be available within an hour after the conference has finished. Please visit our website, www.umc.com, under the Investor Relations, Investors, Events section.
And now, I would like to introduce Mr. Michael Lin, Head of Investor Relations at UMC. Mr. Lin, you may begin.
Thank you, and welcome to the UMC's Conference Call for the Second Quarter of 2018. I'm joined by Mr. Jason Wang, President of UMC; and Mr. Chitung Liu, the CFO of UMC. In a moment, we will hear our CFO present the second quarter financial results, followed by our President's key message to address UMC's forecast and the third quarter 2018 guidance.
Once our President and CFO complete their remarks, there will be a Q&A session. UMC's quarterly financial reports are available at our website, www.umc.com, under the Investors Financial section.
During this conference, we will make forward-looking statements based on management's current expectation and beliefs. These forward-looking statements are subject to a number of risk and uncertainty that could cause actual result to differ materially, including the risk that may be beyond company's control. For these risks, please refer to UMC's filing with the SEC in the U.S. and the ROC securities authorities.
Now I would like to introduce UMC's CFO, Mr. Chitung Liu, to discuss our second quarter 2018 financial results.
Thank you, Michael. I would like to go through the 2Q '18 investor conference presentation material, which can be downloaded from our website. Starting on Page 3, the second quarter of 2Q '18 consolidated revenue was TWD 38.85 billion with gross margin at 17.2%. The net income attributable to the stockholder of the parent was TWD 3.66 billion, and the earnings per ordinary share was TWD 0.30. Utilization rate increased to 97% in Q2 from 94% in Q1. Our cash has stayed around TWD 750 billion at the end of the second quarter.
On Page 4, our statement of income. Revenue was fueled by shipment increase, quarter-over-quarter by 3.6% to TWD 38.8 billion. Gross margin rate is 17.2% or TWD 6.67 billion. And our non-operating income due to the weakness in renminbi against U.S. dollars. So we pretty much gave back all the ForEx gain we booked in Q1, result in negative of TWD 1 billion non-operating loss in second quarter. But still our end result in terms of net income attributable to stockholders still increased about 7.6% or reached TWD 3.659 billion equivalent of EPS TWD 0.30 in second quarter.
For the first 6 months of the year, on Page 5, revenue increased 1.9% year-over-year, mainly due to shipment increase, and our operating expenses is still under tight control. And therefore, as a percentage, it has come off on 15.4% in the first 6 months of 2017 and now is 13.2% in 2018. And our net income in the first half has reached TWD 7 billion, or 61% increase year-over-year compared to the same period of last year. EPS, as a result, is TWD 0.58 compared to TWD 0.36 in 2017.
On Page 6, in terms of our balance sheet, our cash remained around TWD 75 billion with total asset of TWD 380 billion. For Page 7, our ASP in the quarter remained relatively stable. And in terms of revenue breakdown by geography on Page 8, Asia has increased to 51% in the second quarter, while North America went down to 37% in quarter 2, a decline of 5 percentage points compared to that of Q1.
And IDM versus Fabless remained unchanged on Page 9 and segment breakdown on Page 10, also relatively stable. Computer went up slightly to 16% in second quarter.
In second quarter, our technology breakdown on Page 11, we are happy to see the 14 nanometer is now 3% of our total revenue and 40-nanometer came down slightly to 26% from 3% in first quarter of 2018. And second quarter capacity on Page 12, we show 3% plus increase, mainly due to the lower pace in Q1 because of annual maintenance and shorter working days.
In third quarter, we will continue to see a little over 1% capacity increase, mainly coming from our Xiamen facility as well as some expansion in our Singapore site. On Page 13, our annual budget CapEx remained unchanged at NT -- USD 1.1 billion for the time being. The above is the summary of UMC result for second quarter 2018. More details are available in the report, which has been posted on our website.
I will now turn the call over to co-President of UMC, Mr. Wang.
Thank you, Chitung. Good evening, everyone. Here I would like to update the second quarter operating results of UMC. In the second quarter, foundry revenue increased 3.6% sequentially to TWD 38.77 billion. Foundry operating margin was 8.4%. Overall capacity utilization reached 97%, that brings wafer shipment to about 1.85 million 8-inch equivalent. The operating results from second quarter '18 reflect full utilization from our 8-inch and mature 12-inch technologies, driven by strong demand in computing and communications segment. This led to our first half EPS of TWD 0.58, while generating TWD 13.42 billion in free cash flow.
To further take advantage of this healthy demand situation, our Board of Directors approved for the company to supplement UMC's mature 12-inch process capacity through the full acquisition of Fujitsu's 300-millimeter MIFS Semiconductor fab in Japan.
The Board of Directors also approved a plan for our China-based operation to apply for listing on the Shanghai Stock Exchange, led by UMC's HeJain operation. We project third quarter demand outlook to remain flat due to rising inventory levels from slower smartphone digestion and also the uncertainty surrounding the ongoing U.S.-China trade tensions. Despite the current market situation, UMC has always focused on expanding our global scale to enhance our customer value by providing a diversified manufacturing base across Asia that is also strategically positioned near our Taiwan headquarters for seamless logistical support.
UMC's intention to acquire MIFS Semiconductor and list our China operations on the Shanghai Stock Exchange corresponds with this global expansion strategy and will fuel our long-term foundry competitiveness. We will continue to strive for manufacturing excellence and better position ourselves globally to create benefits for our shareholders and customers and employees.
That was our second quarter results. Now let me go over the third quarter 2018 guidance. Our wafer shipment will remain flat. ASP in U.S. dollar will show a marginal increase. Gross profit margin will be in the mid-teens percentage range and capacity utilization rate will be in the low 90s percent range. For foundry CapEx of 2018, it will remain at USD 1.1 billion. That concludes my comments. Thank you all for your attention. Now we are ready for questions.
[Operator Instructions] Our first question is coming from Randy Abrams from Crédit Suisse.
The first question I wanted to ask was about the Japan fab acquisition. If you could give some more color on the capacity, the utilization and profitability of that fab versus the core UMC? And also for that fab, if there is headroom further expand capacity in that fab?
Well, Randy. Well first, we announced this acquisition. But we're still in the process of the -- close this transaction. And we don't expect to close until January 1, 2019. So before that, I can't really comment on some specifics. But in terms of the future room for the expansion, there are some space for the future expansions. Not much, but I think there will be some [ down room ] for future expansion. Right now, according to what we have received, the current facility runs about 36,800 a month capacity and the maximum expansion could be at a range of 40,000 range, yes.
Okay. Great. I appreciate that. The second question, Chitung, you added on your CapEx comment for the time being, you had spent about 30% of the full year guidance. So I'm curious if you do expect kind of back-half loaded, and there are certain projects to invest in? And the second part, for the mature 12-inch and 8-inch, which are running full, if there is existing space or plans or ability to get additional capacity for those technology nodes?
Yes. I think the ongoing effort for debottlenecking production facility is business as usual. We will continue to do so, but the incremental capacity increase will be quite minimum. However, we did mention before that, again, we'll conduct about 15,000 wafer expansion on top of this current [ 64,000, 65,000 ] wafer monthly capacity. But it may take up to 12 months to see some upward from the newly expanded capacity. And in terms of CapEx, for now, it's $1.1 billion because it's relatively low number compared to our past few years, a month. So there may be some kind of fluctuation, at the end we conclude the whole 2018.
Okay. The last question on the other income. If you could give color or guidance for either operating income, and also, the noncontrolling interest? How we should expect that to trend? And maybe in the quarter, kind of what drove the increase? And then how do you see those lines progressing?
[ Non-op ] is a bit difficult. It's highly relied on the, as I mentioned earlier, renminbi against U.S. dollar term, given our China Xiamen facility, currently has a USD 1 billion senior loan outstanding. So the currency movement is the key factor for Q1 and Q2 in terms of the result for nonoperating. As for minority interest, that has been quite stable. Relatively speaking, about 1/3 of Xiamen's loss for now will be recognized or reversed by the end of the financial statement. So noncontrolling interest, 1/3 of the UMC, the 12X loss will be shared by our 2 local investor partners. And given the expanding capacity and also operating scale for our 12X, the overall operating loss is actually larger than that in 2017.
Okay. Chitung, one other line, there is one for net other operating income, which grew -- is TWD 1.72 billion. I guess, also for that line, what's kind of driving that line? And what you see for that net other operating income?
Yes, that line is mainly coming from the subsidies from our China operation. And the normal number should be somewhat similar to that in Q1. In quarter 2, we received a one-off annual subsidy for some investment activities in 2017. So that will be a one-off. For third quarter, this line, the operating line, the other operating income expenses should go back to the level in quarter one.
Okay. Would you get that once a year, like annual, like, say, in second quarter for the prior year?
I think, I believe so, next year. But this kind of seems -- you never know until you really received the money in your pocket.
And the next one is coming from Bill Lu from UBS.
I want to follow up on Randy's question on capital spending. If you look out into next year, now that -- just assuming that the Fujitsu Mie deal is completed, does that impact your outlook for 2019 CapEx?
Well, first of all, it's too early for us to comment on 2019 CapEx. And for Mie acquisition, our main goal will be to drive the synergy first before we plan for further expansion. I'm not sure, if Jason want to comment on that.
Yes, I mean, at this point, I think the current capacity Mie is sufficient to sustain the current business plan. Not until we fully integrate the operation, and we can't really tell what will be the next step for the CapEx plan for Mie.
Yes. So I didn't mean CapEx for the Fujitsu. I guess, I just -- now that you've got some new capacity coming in already from Fujitsu, does that lessen your requirement to expand in Taiwan?
Oh. Well, if we look at the current demand situation, we have actually slowed down our pace of 12-inch expansion for our Xiamen set specifically. The capacity addition to -- that we're looking at is now truly just focused on how can we get that to reach economic scale, which we target at about 25,000 a month, and the Xiamen is running at around 17,000 per day. The slower 12-inch capacity expansion truly just reflect the current market outlook that we have. And meanwhile, we will continue tracking that, and adjust it, but at this point, I think, we are cautious about our CapEx spend in general.
Great. Secondly, on your guidance for the third quarter, you are guiding for ASP to increase slightly and margin to be -- it looks like down a little bit. Is that just conservatism on the margin part? Or can you talk a little bit more about how those 2 things fit together?
Well, we guided Q3 '18 gross margin in the range of mid-teens, right? In 2-year resulting from a flattish shipment that we guided. That would be a -- we see shipment at a flattish rate and with the marginal increase of ASP on branded product mix. But within the product mix, we do see some lower 40 nanometer contribution in Q3 '18, so which -- that will affect our gross margin along with other factors during the summertime, we also see higher utility cost.
Is the increase in ASP a function of higher 28? Or can you talk a little bit more about that 28 was 15% of sales, up from 10%, what's your expectation for the third quarter?
We see 28 and below, that will be a flat between Q2 and Q3, but 40 will actually reduce. So the overall -- that actually -- slightly increase of ASP is really coming from the mature note as with our 8-inch, but that was compensated by the slowdown of 40 nanometers.
I see. So ASP getting a little bit better for 8-inch and 20-inch, 12-inch?
Yes.
And next we'll hear from Michael Chou from Deutsche Bank for questions.
My first question, sir. What will be the 20 nanometers sales portion in Q4, if you can provide some color?
For Q4?
Yes.
Yes. I mean, we don't really comment on Q4 outlook. Given the recent elevated inventory level of the smartphones and some of the uncertainty on the market, we are cautious about our Q4 but we don't comment on the Q4 outlook yet.
Yes. But for your 20-nanometer, what kind of main application for your 28-nanometer in Q3?
Well the -- they're entirely coming from [ India ] communication and also computer area, that includes WiFi as well as some of the flash controllers, yes.
Flash controller. Okay. Second question is regarding your outlook by segment in Q3. Can you provide some color for that?
Outlook for Q3 by application. At this point, look at the -- the weakest will come in from communication. That's very much associated with the Mie and low-end of smartphone situation and followed by the consumer and then the computer. So the weakest will be the communication.
Okay. Other then -- final question is a housekeeping. What is the currency for Q2 when you calculate?
29.77.
Okay. So for your guidance, you just said, look at the current FX, you don't have any assumption, right?
No. We don't have any assumption. No.
And the next question is coming from the Roland Shu from Citigroup.
First question for Mie acquisition. So will you keep Mie fab as it is in configuration and the technology? Or will you benchmark the equipment? Or what kind of technology with your worldwide 12-inch fab?
Well, we -- at this point, without knowing, without getting into the integration process, we are considering both, they both are the options. And because depending upon the product mix, the customers running a different product in a different fab, we may need to keep that option open. But meanwhile, at the same time, we do like to make sure that fabs are transparent to both sides. So both are important to us. But at this point, without the complete integration, I can't really know exactly mix of that.
Yes, understood. But dealing with the same configuration as your Taiwan fab or Singapore fab, will that be very important to you, do you think you'll probably keep the same configuration there is also a doable option?
Well, again, depending on the outlook, and we believe with Mie that we are going to be able to getting -- enhance our exposure in automotive industrial segment, which is a little bit better than what we're doing today. But at the same time, we'll be able to bring some synergy from our larger customer base. So as I said, we will consider both and just -- we don't know exactly what the mix is yet.
Okay. Understood. Yes. Second question for your upcoming IPO for Hejian and 12X. So in order to IPO 12X, are you going to consider to increase your shareholding for 12X?
The listing entity is HeJain and 12X or [ UMC ] is only the subsidiary of both HeJain and UMC. So UMC is not listing.
Okay. So that means it's not in your wealth -- your entity list.
No. So the listing entity is HeJain.
Okay. Understood. Last question. Given there was not much 8-inch capacity or shipment increase in second quarter, but you still grow your 8-inch revenue. So I would like to know for what extent of this 8-inch revenue increase was from the wafer price high capacity? And what kind of spend for this revenue increase is coming from product mix change?
Well, we don't have a specific mix breakdown, but the increase on the 8-inch blend is really coming from field. One is the productivity improvement, means we have increased some of the wafer outlook through the productivity improvement. And same time for the product mix, the improvement, and we have [ stopped ] making some headway there. The last is the -- we did increase some of the cost from the wafer material. So we passed through those cost difference to the 8-inch customer, but it's not changing entire wafer pricing. So our policy is we do not increase pricing simply because of strong demand, but we are working with our customers to compensate for the wafer cost increases.
Understood. So for the 8-inch product improvement and product mix change even for -- we pass through this cost, you said, we have slightly ASP growth in 3Q. So that means that this will be well maintained in 3Q, so that means in 3Q, that 8-inch revenue probably will continue to grow, however, the overall 12-inch will decline, is that right?
Yes. I mean, in general that's correct. We do see the 8-inch capacity load continue to be [ full ] in the following quarter, and the 12-inch mature is healthy, while the 14-nanometer is actually declining, yes.
And the next one is from Donald Lu from Goldman Sachs.
First question is, what is this other operating income of TWD 1.7 billion in second quarter?
Yes, that's the subsidies from our Chinese operation in Xiamen.
I see. That's a one time? Or is that going to be every quarter going forward?
This will be every quarter, but the amount should be similar to Q1. Q2 will receive a one-time annual subsidy from 2017.
I see. Yes. My second question is about this potential A share listing. I understand that the R&D for 12-inch research and also probably for HeJain are going to be accomplished in Taiwan in the UMC entity in Taiwan. How do you transfer the technology to the China entity via listing? I mean, what kind of guarantee you give to the China entity for R&D transfer?
Yes. Further detail of application, given that we haven't really submit the application yet. The next [ further ] is we will have AGM in Taiwan on August 20, and then we will prepare the document and get ready to send in the application. So we are not to that step yet. For the time being, all of the UMC operation has been following the same kind of practice over the past years.
But if Chinese SEC will be okay with this kind of arrangement because apparently, the technology transfer would subject to a lot of the political risks?
Yes. As I mentioned, we haven't really submit the application. Every time there's a technology license from UMC to our subsidiary in China it all was approved by both Taiwan government as well as the Chinese authorities.
I see. Great. My final question is, in the prepared remarks, you said that third quarter outlook is impacted by U.S.-China trade tensions. Is there any specific case or customers or areas that is causing this kind of concern?
Well, we see some signs. So that's why we're observing the development very carefully with the hope that it's not going to be any impact. But however, we won't be able to control that. So that's how we are cautious about that.
I see. Okay. Is ZTE a customer of UMC?
Not directly.
And then the next question is coming from Charlie Chan from Morgan Stanley.
So my first question is on your third quarter gross margin trend, right, because your shipment is flat and you have some nodes, you have ASP hike, right? So I suppose the -- your gross margin should go up, because you have ASP hike, right? So what do we miss on the gross margin assumption?
Yes, a couple. First of all, the third quarter normally, we will see higher operating costs. Also, the utility cost is higher in the third quarter as well as our annual compensation adjustment. And secondly, we will also see some unfavorable mix, 14-nanometer, which still carry much bigger depreciation against our 8-inch operations. So cost wise, it's more unfavorable in terms of product mix point of view.
Okay, got it. And also regarding the government subsidiary, I'm sorry, is that a cash item? And will you need to amortize those subsidies in the coming years? And lastly, because my understanding is that the subsidy comes from the loss, right? So if the [ fabless ] turn around, make money, do you need to return those subsidies?
These subsidies, not so much related to operating result. It's more related to our CapEx and also our borrowing costs. So it is a result of amortization already.
Okay. So you will need to amortize those...
It's actually already been amortized.
Okay, I see. And is that a cash item or accounting GAAP?
It's cash.
Cash, okay. And lastly, can you comment a little bit on the low wafer price? And what does it mean to your wafer price in the coming quarters?
Well, we are seeing a low wafer price increase on 8-inch particularly from the last year to this first half of this year in the double-digit range significantly. So we start pass -- discussing with the customers about passing through those cost increase to the customer and that happened in last quarter and we will continue this practice. And so we do see that or recover some of our 8-inch ASP, but not going to be a significant way, yes.
Okay. One more, if I may. So I think your competitor, TSMC, talked about 28-nanometer utilization could decline again in 2019 before you ramp up in 2020. And they hope to fulfill their 28-nanometer fab with those AI, those new applications. So what would be your kind of mid- to long-term outlook for 28-nanometer business? What will be the new growth drivers for this business line?
Well, we -- the -- we do see some transitional product applications and the -- we see AIoT, we see the high voltage. We see those applications will continue going in -- coming into the 28. But that's more of the product trend. For UMC specifics, we are facing multiple ways to involving technology on the 28 high-k, which -- that puts UMC more in a recovery mode right now. And so once we start getting ready, from a technology standpoint, and we will start seeing new customer base in this area more fragments more than volume. So we're coming from those applications, but those customers will be more fragmented and more volume. And our current issue, the near-term issue is more of a technology readiness as -- when this continues evolving technology in the 28 high-k.
And the next one is from Sebastian Hou from CLSA.
My first question is on the -- you have a very nice rebound, or growth, of the 40 nanometer and 28 in second quarter. Can you give us some colors on what type of applications is that?
Well, currently, we still concentrate in the communication area. So the baseband, RF, those areas are still our main drivers for 28, yes.
How about 14?
14 is actually with a very limited capacity as well as the customer base. I'd rather not comment on the 14.
Okay. So can we assume that your 14, the application has been pretty much the same since the beginning?
Yes, yes.
Okay, got it.
[indiscernible].
All right. Well -- but that's good enough. So how about the outlook into third quarter? I remember, Jason, you mentioned it will be flat in -- for the quarter, but how about into the first quarter and next year? Are you confident in further grow -- to further grow this product revenue?
Well, I mean, if you look at 28 product mix situation, I think there will be a continued product migration path going. So we are expecting other application coming into 28, but we also expecting, on the product, we're migrating out of 28. So we'll continue going through that process until our 22 get ready, most likely will be in the time frame of 2019, yes. So I think we'll continue seeing the product application mix change throughout this time, yes.
Okay. So which means that it's fair to assume your 28 nanometers, although there is a nice rebound in second quarter, but will probably remain at this level for the next few quarters?
Well, that will be our goal to maintain, but it's also subject to the outlook, right? I mean, whether it's on the market or the early transition of product. So that could change. But as I said, we probably have to go through this whole process quarter-by-quarter, yes.
Okay. Second question is your gross margin in second quarter improved about 5 percentage point, but you -- when I look at your process node mix, 40 nanometers above nodes, U.S. dollars revenue down about 3%; while your 28, 14 revenue, up 30% quarter-on-quarter. But if I understand correctly, those nodes should carry lower margin than the mature nodes, but your margin improved from 5 percentage point. Can you explain a little bit that? Is it because of the overall structure margin improving on those nodes? Or any other particular reason?
Mostly coming from a better capacity utilization base. So we're virtually running at the full capacity, 97% in the second quarter. So that definitely helped the gross margin side and...
Right. But you -- like UTR in the first quarter was 94%, right, but only 3 percentage -- 3% point -- I'm sorry, 3% from the UTR. Is that significant enough to give you a 5% point of the margin improvement?
Yes. In terms of single fab difference, yes, that's actually quite a big swing factor. So if you look at the overall 94% versus 97%, it may not be that big difference. But if you look at the single wafer fab, the swing actually is quite big.
So if I interpret that correctly because the advanced nodes have seen the largest change in second quarter. So the delta there -- or the leverage there is higher?
Yes.
Okay. Third question is on the Fujitsu fab acquisition. Can you give us more colors on the -- what type of customers, application of this fab is? And how easy for you to ramp up this fab and to, say, to pour your current customer to that fab?
Well, the current Mie fab, the MIFS 12 inch, kind of quite diverse. They have communication, consumer, automotive and the computer, industrial. They're quite diverse. And there are some major customers in the communication area. So it will be very complementary to our current customer portfolio. And -- but as far as other synergies, we just have to get closer to the integration stage, so I can comment that, yes.
Okay. Or I'll ask it for another way is that the -- before you do anything, do any integration to this fab, as I said, this starts from the early next year, would this fab be earnings accretive without doing anything? I mean, without you doing any integration, that's what I mean.
Again, this one is a subsidiary of Fujitsu company right now, so I cannot comment on the future profitability of this particular operation. We will only start to be able to comment on the operational profitability after January 1, 2019.
Okay. Fourth question for me is the -- regarding your Asia listing, also, I think in your announcement, you also said that we'll use the funding from the listing to add capacity of Hejian fab by 15%. Is the 8-inch fab -- and I know the equipment availability is pretty low right now. So how confident are you to increase capacity by 15%?
That is a -- very comfortable -- we're very comfortable of that. And I think we don't see a concern about capacity in Hejian, yes.
Okay. So does that mean that you have already secured or locked down some equipment?
Right. So that's already in discussion, yes.
Okay. But why not like add in now or earlier? Why do you need to wait for like IPF or IPO if you already secured equipment?
For the current [ frame ] of capacity expansion in Hejian, that's already underway. The future of the listing assume the IPO is successful and the fund will be -- also come to the future expansion. We haven't get into that future expansion discussion yet. So I told you I was referring to the current expansion plan.
Okay. So this 15% expansion is not relevant to the Asia listing? Or they are still relevant?
For the next 10,000-wafer capacity increase, it's not -- it's our current CapEx plan. That's already in discussion, yes.
Let me clarify that. I do have the expansion plan for now and it's ongoing. And the proceeds on IPO is coming on time. They can still use to pay for it. So that was the idea. It's not the other way around. So the capacity expansion will go through with or without this IPO. But with the IPO proceeds, the use of proceed is actually to provide this tranche, also may be the future tranche of the Hejian expansion.
Okay. So easier too for us to say though, regardless of the IPO plan, you will like definitely expand that 15% capacity?
Yes, yes.
And the time line -- tentative time line is 2019?
Second quarter next year, yes, yes.
Second quarter next year, okay. Second quarter next year, we'll start to see that -- okay, capacity increase. Last one is just -- sorry, for me is that since you already share some of the cost burden with your customer by raising your foundry wafer price, do you expect this to continue, which means that -- do you expect the wafer cost to continue to go up, so you continue to reflect this kind of price hike to your customers?
Well, it does continue to increase, and our plan is we will work with our customer for the wafer cost increase, yes.
All right, yes. So are you seeing the cost continue to increase?
We see the pricing start fluctuating a little bit. Now the discussion is how to increase the supply in this area and to increase the capacity by bringing new facility and will cause a new price increase and then we have to address that.
Okay. You -- sorry, just to clarify, so Jason, you mean that the wafer cost increase has kind of -- [ mandatory ] had kind of saturated?
That's right, yes. [indiscernible] I was talking about the increase of the supply. And if that falls, the supplier need to go into and put in a new facility. And if that attributes to the new cost increase, then there will be a new discussion again. So at this point, I -- we can't really comfortable saying there's no more slight increase, but we do see that saturate a little bit, yes.
You're talking about both -- you're referring to both 8-inch and 12-inch, right?
Yes, now that [indiscernible] more on availability now.
[Operator Instructions] And next, we'll have Aaron Jeng from Nomura Securities for questions.
Number one, I want to clarify that mid-teens, from your company's definition, is which range? It's somewhere like 16% to -- 14% to 16% or it's wider range? And -- because I wonder whether the 2Q result, which was 17%, whether it included the range of mid-teens? That's my first question.
Well, that's -- I will say plus, minus 1.5%, above or below 15%.
Okay, that's [ guided ]. So 2Q was a bit...
2Q was close, yes.
Okay. So maybe a follow-up. So why the 2Q beat, but what went right versus 3 months ago when you gave it a forecast?
I think there was an earlier question asking about it. It's mainly a swing factor from a better utilization rating, our leading-edge capacity.
Okay, no problem. Look, the second question is that I just -- I want to clarify, you got the lower 40-nanometer revenue into third quarter and -- which [ leaves ] associated with a slower trend smartphone demand over, say, inventory correction.
Yes.
Okay. And my last question is on 28-nanometer outlook. Earlier, you replied to one question that, correct me if I'm wrong, that you were unable to comment on whether the 28-nanometer revenue going to stay at current level for maybe the next couple of quarters. Is this right? Because you said that depends on the market situation before you fully ramp the 22 nanometer? I don't know whether this is the right statement from you.
Well, we only give out quarterly guidance. So for the Q3 '18, we're saying the 28 and below will be flat from Q2 '18.
Yes, okay. And so how about technology progress right now? You earlier -- I think at every conference call, you give out the [ separate ] schedule, investor [ guidance ] schedule. For 22 nanometer, are any of these changed?
For 22?
Yes, 22 and -- yes, 22, yes.
The 22 is currently under development stage, and the project is on track. We do expect 22 tape-out will happen in early 2019 and followed by the pilot production.
Okay. So one -- just a scenario, into second half of next year, assuming that 22 nanometer start ramping, should we assume 22-nanometer revenue contribution to be same like probably more at 50% of your 28-nanometer family? Yes, that's my question.
Well, it's hard to predict that far out because revenue contribution really coming from the success of a customer product that we engage. So we're getting good discussion with the customer, but first of all, we have to deliver that first. So since this is still under development and we just want to make sure that we deliver what we have, align it with our customers first.
Ladies and gentlemen, we are running out of time. So we're taking the last question. And the last question is from Charlie Chan from Morgan Stanley.
So first of all, regarding the shipment fab acquisition, did you ever disclose the valuation, I mean, the price of bulk PE even it's from last year's financial?
The price is a onetime book, yes, and I believe their [ uphold ] P&L is a public information from Fujitsu's filing. So you may want to look it up, basically small profit in the previous calendar year -- fiscal year.
Okay. So is there so called contingent liability, because I think Japan really cared about employees benefits, right, like pension fund, et cetera, right? So is that going to drag Japan's fab earning contribution going forward?
Well, without disclosing the other too much details, basically, we are paying onetime book, and that's it.
Okay, okay. And lastly, can you give us some update regarding the patent infringement from Micron? I mean, do you expect that your IP claim can apply to more Micron's products, even some more fundamental IP that can apply to the overall Micron's process. Can you comment on that?
Well, first of all, there are a few of the litigations ongoing between UMC and Micron in China, Taiwan and U.S., okay? So owing the ongoing natural litigation, we are limited to -- on how much we can comment on the -- for the time being. The [indiscernible] I would probably -- I can mention is, one, is we take the IP protection very seriously and we conduct our operations with integrity and transparency. So we respect our customers, the foundry company will respect our customer for private information, IP rights very much. So in the same time, the -- when we review, when we have -- we see this as attack from Micron, we review our intellectual property between the 2 parties and discover that we have some intellectual property failed to respect by Micron. So that's how we filed the patent infringement suit against Micron in China. But that wasn't really -- it wasn't our intention to impact this because we only look at this from a Micron product line infringement, what's being infringed and we haven't really gone into much of the detail yet. So that's kind of where we are, yes.
Okay, okay. I know it's quite sensitive since it's [ all of the color ].
We thank you for all your questions. That concludes today's Q&A session. I will turn things over to UMC Head of IR for closing remarks.
Thank you, everyone, for attending this conference today. We appreciate your questions. As always, if you have any additional follow-up questions, please feel free to contact UMC at ir@umc.com. Have a good day.
And ladies and gentlemen, that concludes our conference for second quarter 2018. We thank you for your participation in UMC's conference. There will be a webcast replay within an hour. Please visit www.umc.com under the Investors, Events section. You may now disconnect. Goodbye.